Clinical Trials Logo

Clinical Trial Summary

Diabetes represents one of the 10 leading causes of death in the world and concerns 5% of the French population (> 3.3 million patients). About 30% of diabetic patients will develop heart failure. The specific and early identification of diabetic cardiomyopathy at a subclinical stage (asymptomatic patients with normal LVEF) will thus make it possible to predict the risk of the onset of heart failure and to strengthen their monitoring and further adapt their treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04593173
Study type Observational
Source University Hospital, Strasbourg, France
Contact Samy TALHA, MD
Phone 33 3 69 55 13 68
Email samy.talha@chru-strasbourg.fr
Status Recruiting
Phase
Start date October 1, 2020
Completion date November 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04083339 - Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Phase 3
Recruiting NCT05556005 - Efficacy of Trimetazidine in Diabetic Patients Phase 2
Completed NCT03299790 - Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy N/A
Recruiting NCT03132129 - Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
Not yet recruiting NCT04534894 - Single-center Clinical Study of Early Diagnosis of Diabetic Cardiomyopathy With FLIM
Terminated NCT04141475 - Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy N/A
Completed NCT03049228 - In and ex Vivo Mitochondrial Function of the Heart
Completed NCT03930004 - Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
Not yet recruiting NCT05571865 - Diabetic Cardiomyopathy and Heart Failure N/A
Recruiting NCT05958706 - Mitochondrial Substrate Utilization in the Diabetic Human Heart
Recruiting NCT04591639 - The DAPA-MEMRI Trial N/A
Recruiting NCT04826159 - IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) Phase 2
Enrolling by invitation NCT05915260 - CMR in T2DM: The NSR Cohort